Posts


 |  |



South African Innovator of the Year is set to save the lives of HIV-infected children

An age-appropriate, child-friendly antiretroviral drug (ARV) for children living with HIV/AIDS may offer a solution to these grim statistics ... View article...

Project competitions for the prevention of tuberculosis and HIV

In parallel, the competition for HIV prevention and risk reduction among key affected groups is open. The projects will be implemented over the next ... View article...

Long-acting HIV PrEP registration brings us another step closer to ending HIV for Australia

A clinical trial involving more than 3,000 participants from different populations saw HIV infections decrease by 96 per cent, proving its benefit to ... View article...

The truth about HIV phobia in gay dating

HIV and stigma remain baked into queer dating culture, leaving many men living with the virus to navigate rejection, discrimination and shame. View article...

Study warns Uganda's anti-LGBT laws are affecting their response to HIV

A new study has shown that Uganda's strong stance against homosexuality may be having a negative effect on their attempts to reduce HIV . View article...

Ministry approves long-acting HIV prevention drug for rollout

The injection is given once every six months and prevents HIV infection even in unprotected sex. View article...

Kenya approves long-acting HIV prevention injection Lenacapavir

Kenya has approved Lenacapavir, a twice-yearly HIV prevention injection, after a rigorous regulatory review by the Pharmacy and Poisons Board. View article...

HIV funding falls short of targets as millions of lives hang in the balance

African governments must allocate their own resources for HIV programmes, through budget prioritisation, health insurance schemes, and innovative ... View article...